Israel Englander’s NeoGenomics NEO Stock Holding History

Israel Englander’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-250,000	Closed	-$1.93M	–	6309
2025 Q3	$1.93M	Hold	250,000	–	–	﹤0.01%	4089
2025 Q2	$1.83M	Sell	250,000 -25,000	-9%	-$202K	﹤0.01%	3960
2025 Q1	$2.61M	Buy	+275,000	New	+$3.43M	﹤0.01%	3526
2024 Q2	–	Sell	-345,000	Closed	-$5.42M	–	6323
2024 Q1	$5.42M	Buy	345,000 +125,000	+57%	+$1.93M	﹤0.01%	2781
2023 Q4	$3.56M	Buy	220,000 +70,000	+47%	+$1.15M	﹤0.01%	3089
2023 Q3	$1.84M	Buy	+150,000	New	+$2.23M	﹤0.01%	3628
2022 Q3	–	Sell	-219,200	Closed	-$1.79M	–	7353
2022 Q2	$1.79M	Buy	+219,200	New	+$2.09M	﹤0.01%	3824
2021 Q4	–	Sell	-200,000	Closed	-$9.65M	–	7177
2021 Q3	$9.65M	Buy	+200,000	New	+$9.26M	0.01%	2098

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Israel Englander's NEO Position: Q2 2026 in Review

Israel Englander increased its NeoGenomics (NEO) stake by 39% in Q2 2026, buying an estimated $8.27M and bringing the position to 3,079,542 shares worth $44.9M. The position accounts for 0.02% of the portfolio, ranked #965.

Israel Englander first reported a position in NEO in Q4 2013 and has held it in 40 quarters since. The position peaked at $63.8M in Q1 2025. 265 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Israel Englander held 3,079,542 shares of NeoGenomics worth $44.9M as of Q2 2026.
Israel Englander bought 856,785 NeoGenomics shares in Q2 2026, an estimated $8.27M.
NeoGenomics made up 0.02% of Israel Englander's portfolio in Q2 2026, its #965 holding.
Israel Englander first reported a position in NeoGenomics in Q4 2013 and has held it in 40 quarters since.
Israel Englander's NeoGenomics position peaked at $63.8M in Q1 2025.
265 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.